Jefferies Group LLC reaffirmed their buy rating on shares of Genpact Limited (NYSE:G) in a research note published on Friday.

G has been the topic of a number of other research reports. Cantor Fitzgerald reissued an overweight rating and set a $27.00 price objective on shares of Genpact Limited in a report on Friday, February 10th. Zacks Investment Research raised Genpact Limited from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Tuesday, December 6th. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of $28.38.

Shares of Genpact Limited (NYSE:G) opened at 24.22 on Friday. Genpact Limited has a 52-week low of $22.58 and a 52-week high of $28.52. The stock has a market cap of $4.82 billion, a PE ratio of 18.92 and a beta of 0.63. The company’s 50-day moving average price is $24.09 and its 200-day moving average price is $24.08.

Genpact Limited (NYSE:G) last issued its earnings results on Friday, February 10th. The business services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.04. Genpact Limited had a return on equity of 21.52% and a net margin of 10.49%. The company had revenue of $682 million for the quarter, compared to analyst estimates of $684.81 million. During the same period in the prior year, the firm posted $0.34 EPS. The business’s revenue was up 5.5% compared to the same quarter last year. Analysts expect that Genpact Limited will post $1.55 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Jefferies Group LLC Reaffirms “Buy” Rating for Genpact Limited (G)” was first published by Marea Informative and is owned by of Marea Informative. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at http://www.mareainformativa.com/genpact-limitada-g-dado-comprar-calificacion-de-jefferies-group-llc/108955/.

The firm also recently announced a special dividend, which was paid on Tuesday, March 28th. Investors of record on Friday, March 10th were paid a dividend of $0.06 per share. The ex-dividend date was Wednesday, March 8th.

In other Genpact Limited news, insider Arvinder Singh sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, February 3rd. The stock was sold at an average price of $24.99, for a total value of $249,900.00. Following the completion of the sale, the insider now owns 70,478 shares in the company, valued at approximately $1,761,245.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider N. V. Tyagarajan sold 198,642 shares of the firm’s stock in a transaction that occurred on Thursday, March 9th. The stock was sold at an average price of $24.09, for a total value of $4,785,285.78. Following the completion of the sale, the insider now owns 477,787 shares of the company’s stock, valued at approximately $11,509,888.83. The disclosure for this sale can be found here. Insiders sold a total of 228,642 shares of company stock valued at $5,525,186 in the last quarter. Corporate insiders own 1.55% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. William Blair Investment Management LLC purchased a new stake in shares of Genpact Limited during the fourth quarter worth approximately $143,566,000. Congress Asset Management Co. MA bought a new position in Genpact Limited during the fourth quarter valued at approximately $46,075,000. Norges Bank bought a new position in Genpact Limited during the fourth quarter valued at approximately $32,718,000. Fiera Capital Corp bought a new position in Genpact Limited during the second quarter valued at approximately $30,903,000. Finally, Frontier Capital Management Co. LLC bought a new position in Genpact Limited during the fourth quarter valued at approximately $23,542,000. Institutional investors own 90.37% of the company’s stock.

About Genpact Limited

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

5 Day Chart for NYSE:G

Receive News & Stock Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related stocks with our FREE daily email newsletter.